Wu L - Search Results

1

A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action.

Li X, Wu L, Liu W, Jin Y, Chen Q, Wang L, Fan X, Li Z, Cheng Y. Li X, et al. Among authors: wu l. PLoS One. 2014 May 9;9(5):e95004. doi: 10.1371/journal.pone.0095004. eCollection 2014. PLoS One. 2014. PMID: 24817581 Free PMC article.

2

[Prediction of multi-target of Aconiti Lateralis Radix Praeparata and its network pharmacology].

Wu L, Gao X, Wang L, Liu Q, Fan X, Wang Y, Cheng Y. Wu L, et al. Zhongguo Zhong Yao Za Zhi. 2011 Nov;36(21):2907-10. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22308671 Chinese.

3

[Network pharmacology study on major active compounds of Fufang Danshen formula].

Li X, Wu L, Fan X, Zhang B, Gao X, Wang Y, Cheng Y. Li X, et al. Among authors: wu l. Zhongguo Zhong Yao Za Zhi. 2011 Nov;36(21):2911-5. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22308672 Chinese.

4

[Symptom-based traditional Chinese medicine slices relationship network and its network pharmacology study].

Wu L, Gao X, Cheng Y, Wang Y, Zhang B, Fan X. Wu L, et al. Zhongguo Zhong Yao Za Zhi. 2011 Nov;36(21):2916-9. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22308673 Chinese.

5

[Tools for network pharmacology study: network visualization and network analysis].

Wu L, Wang Y, Fan X. Wu L, et al. Zhongguo Zhong Yao Za Zhi. 2011 Nov;36(21):2923-5. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22308675 Chinese.

6

Does applicability domain exist in microarray-based genomic research?

Shao L, Wu L, Fang H, Tong W, Fan X. Shao L, et al. Among authors: wu l. PLoS One. 2010 Jun 10;5(6):e11055. doi: 10.1371/journal.pone.0011055. PLoS One. 2010. PMID: 20548774 Free PMC article.

7

Consensus ranking approach to understanding the underlying mechanism with QSAR.

Shao L, Wu L, Fan X, Cheng Y. Shao L, et al. Among authors: wu l. J Chem Inf Model. 2010 Nov 22;50(11):1941-8. doi: 10.1021/ci100305g. Epub 2010 Nov 4. J Chem Inf Model. 2010. PMID: 21049968

8

Shifting from population-wide to personalized cancer prognosis with microarrays.

Shao L, Fan X, Cheng N, Wu L, Xiong H, Fang H, Ding D, Shi L, Cheng Y, Tong W. Shao L, et al. Among authors: wu l. PLoS One. 2012;7(1):e29534. doi: 10.1371/journal.pone.0029534. Epub 2012 Jan 25. PLoS One. 2012. PMID: 22295060 Free PMC article.

9

A network pharmacology approach to evaluating the efficacy of chinese medicine using genome-wide transcriptional expression data.

Wu L, Wang Y, Nie J, Fan X, Cheng Y. Wu L, et al. Evid Based Complement Alternat Med. 2013;2013:915343. doi: 10.1155/2013/915343. Epub 2013 May 12. Evid Based Complement Alternat Med. 2013. PMID: 23737854 Free PMC article.

10

CHD@ZJU: a knowledgebase providing network-based research platform on coronary heart disease.

Wu L, Li X, Yang J, Liu Y, Fan X, Cheng Y. Wu L, et al. Database (Oxford). 2013 Jul 1;2013:bat047. doi: 10.1093/database/bat047. Print 2013. Database (Oxford). 2013. PMID: 23818526 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,652 results

Search Page

Filters